US Stock MarketDetailed Quotes

HSDTW HELIUS MEDICAL TECHNOLOGIES INC C/WTS 02/02/2026 (TO PUR COM)

Watchlist

0.001
0.0000.00%

15min DelayClose Nov 12 16:00 ET

0Market Cap0.00P/E (TTM)

HELIUS MEDICAL TECHNOLOGIES INC C/WTS 02/02/2026 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-64.34%51K

-28.91%182K

21.62%135K

-18.17%644K

-52.48%134K

-27.04%143K

115.13%256K

-41.58%111K

50.77%787K

9.30%282K

Operating revenue

-69.70%40K

-29.92%171K

16.98%124K

-22.24%605K

-56.23%123K

-32.31%132K

105.04%244K

-42.08%106K

57.81%778K

11.95%281K

Cost of revenue

0.00%187K

-35.87%118K

0.82%123K

25.92%583K

-40.00%90K

85.15%187K

109.09%184K

-1.61%122K

55.37%463K

16.28%150K

Gross profit

-209.09%-136K

-11.11%64K

209.09%12K

-81.17%61K

-66.67%44K

-146.32%-44K

132.26%72K

-116.67%-11K

44.64%324K

2.33%132K

Operating expense

33.36%3.93M

1.31%3.33M

-9.77%3.43M

-18.25%12.33M

-18.24%2.29M

-29.61%2.95M

-4.91%3.29M

-17.95%3.8M

-17.88%15.08M

-33.80%2.8M

Selling and administrative expenses

29.78%2.85M

-4.36%2.46M

-8.39%2.63M

-12.87%9.27M

-17.03%1.63M

-35.28%2.2M

4.39%2.57M

1.95%2.87M

-12.61%10.64M

-17.21%1.97M

Research and development costs

49.17%1.08M

27.19%870K

-11.06%788K

-30.97%2.94M

-18.14%650K

-3.86%722K

-28.23%684K

-49.77%886K

-28.85%4.26M

-56.08%794K

Depreciation amortization depletion

-78.13%7K

-81.58%7K

-82.05%7K

-35.36%117K

-80.00%8K

-31.91%32K

-19.15%38K

-17.02%39K

-9.50%181K

-14.89%40K

-Depreciation and amortization

-78.13%7K

-81.58%7K

-82.05%7K

-35.36%117K

-80.00%8K

-31.91%32K

-19.15%38K

-17.02%39K

-9.50%181K

-14.89%40K

Operating profit

-35.94%-4.07M

-1.58%-3.27M

10.34%-3.42M

16.87%-12.27M

15.85%-2.25M

26.90%-2.99M

6.15%-3.22M

16.52%-3.81M

18.65%-14.76M

34.93%-2.67M

Net non-operating interest income expense

-101.47%-1K

-105.62%-5K

-108.00%-8K

130.82%257K

107.40%68K

89K

100K

-834K

85K

Total other finance cost

101.47%1K

105.62%5K

108.00%8K

-130.82%-257K

--0

-107.40%-68K

---89K

---100K

--834K

---85K

Other net income (expense)

152.24%385K

12.21%1.66M

-25.33%908K

107.89%3.16M

152.17%1.2M

-118.49%-737K

490.00%1.48M

457.80%1.22M

15,110.00%1.52M

-2.3M

Gain on sale of security

156.41%330K

7.42%1.59M

-29.77%854K

42.71%3.24M

148.87%1.13M

-112.34%-585K

490.00%1.48M

460.37%1.22M

22,610.00%2.27M

---2.31M

Special income (charges)

--0

----

79.00%-159K

--0

79.00%-159K

----

---757K

--0

-Less:Impairment of capital assets

--0

----

-79.00%159K

--0

-79.00%159K

----

--757K

--0

Other non- operating income (expenses)

685.71%55K

--71K

--54K

1,042.86%80K

1,116.67%73K

--7K

----

--7K

--6K

Income before tax

-0.63%-3.69M

2.18%-1.61M

-0.88%-2.52M

37.11%-8.85M

78.61%-1.05M

-255.63%-3.66M

56.75%-1.65M

42.61%-2.49M

22.39%-14.07M

-19.11%-4.89M

Income tax

Net income

-0.63%-3.69M

2.18%-1.61M

-0.88%-2.52M

37.11%-8.85M

78.61%-1.05M

-255.63%-3.66M

56.75%-1.65M

42.61%-2.49M

22.39%-14.07M

-19.11%-4.89M

Net income continuous Operations

-0.63%-3.69M

2.18%-1.61M

-0.88%-2.52M

37.11%-8.85M

78.61%-1.05M

-255.63%-3.66M

56.75%-1.65M

42.61%-2.49M

22.39%-14.07M

-19.11%-4.89M

Minority interest income

Net income attributable to the parent company

-0.63%-3.69M

2.18%-1.61M

-0.88%-2.52M

37.11%-8.85M

78.61%-1.05M

-255.63%-3.66M

56.75%-1.65M

42.61%-2.49M

22.39%-14.07M

-19.11%-4.89M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-0.63%-3.69M

2.18%-1.61M

-0.88%-2.52M

37.11%-8.85M

78.61%-1.05M

-255.63%-3.66M

56.75%-1.65M

42.61%-2.49M

22.39%-14.07M

-19.11%-4.89M

Basic earnings per share

Diluted earnings per share

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	-64.34%51K	-28.91%182K	21.62%135K	-18.17%644K	-52.48%134K	-27.04%143K	115.13%256K	-41.58%111K	50.77%787K	9.30%282K
Operating revenue	-69.70%40K	-29.92%171K	16.98%124K	-22.24%605K	-56.23%123K	-32.31%132K	105.04%244K	-42.08%106K	57.81%778K	11.95%281K
Cost of revenue	0.00%187K	-35.87%118K	0.82%123K	25.92%583K	-40.00%90K	85.15%187K	109.09%184K	-1.61%122K	55.37%463K	16.28%150K
Gross profit	-209.09%-136K	-11.11%64K	209.09%12K	-81.17%61K	-66.67%44K	-146.32%-44K	132.26%72K	-116.67%-11K	44.64%324K	2.33%132K
Operating expense	33.36%3.93M	1.31%3.33M	-9.77%3.43M	-18.25%12.33M	-18.24%2.29M	-29.61%2.95M	-4.91%3.29M	-17.95%3.8M	-17.88%15.08M	-33.80%2.8M
Selling and administrative expenses	29.78%2.85M	-4.36%2.46M	-8.39%2.63M	-12.87%9.27M	-17.03%1.63M	-35.28%2.2M	4.39%2.57M	1.95%2.87M	-12.61%10.64M	-17.21%1.97M
Research and development costs	49.17%1.08M	27.19%870K	-11.06%788K	-30.97%2.94M	-18.14%650K	-3.86%722K	-28.23%684K	-49.77%886K	-28.85%4.26M	-56.08%794K
Depreciation amortization depletion	-78.13%7K	-81.58%7K	-82.05%7K	-35.36%117K	-80.00%8K	-31.91%32K	-19.15%38K	-17.02%39K	-9.50%181K	-14.89%40K
-Depreciation and amortization	-78.13%7K	-81.58%7K	-82.05%7K	-35.36%117K	-80.00%8K	-31.91%32K	-19.15%38K	-17.02%39K	-9.50%181K	-14.89%40K
Operating profit	-35.94%-4.07M	-1.58%-3.27M	10.34%-3.42M	16.87%-12.27M	15.85%-2.25M	26.90%-2.99M	6.15%-3.22M	16.52%-3.81M	18.65%-14.76M	34.93%-2.67M
Net non-operating interest income expense	-101.47%-1K	-105.62%-5K	-108.00%-8K	130.82%257K	0	107.40%68K	89K	100K	-834K	85K
Total other finance cost	101.47%1K	105.62%5K	108.00%8K	-130.82%-257K	--0	-107.40%-68K	---89K	---100K	--834K	---85K
Other net income (expense)	152.24%385K	12.21%1.66M	-25.33%908K	107.89%3.16M	152.17%1.2M	-118.49%-737K	490.00%1.48M	457.80%1.22M	15,110.00%1.52M	-2.3M
Gain on sale of security	156.41%330K	7.42%1.59M	-29.77%854K	42.71%3.24M	148.87%1.13M	-112.34%-585K	490.00%1.48M	460.37%1.22M	22,610.00%2.27M	---2.31M
Special income (charges)	--0	----	----	79.00%-159K	--0	79.00%-159K	----	----	---757K	--0
-Less:Impairment of capital assets	--0	----	----	-79.00%159K	--0	-79.00%159K	----	----	--757K	--0
Other non- operating income (expenses)	685.71%55K	--71K	--54K	1,042.86%80K	1,116.67%73K	--7K	----	----	--7K	--6K
Income before tax	-0.63%-3.69M	2.18%-1.61M	-0.88%-2.52M	37.11%-8.85M	78.61%-1.05M	-255.63%-3.66M	56.75%-1.65M	42.61%-2.49M	22.39%-14.07M	-19.11%-4.89M
Income tax	0	0	0	0	0	0	0	0	0	0
Net income	-0.63%-3.69M	2.18%-1.61M	-0.88%-2.52M	37.11%-8.85M	78.61%-1.05M	-255.63%-3.66M	56.75%-1.65M	42.61%-2.49M	22.39%-14.07M	-19.11%-4.89M
Net income continuous Operations	-0.63%-3.69M	2.18%-1.61M	-0.88%-2.52M	37.11%-8.85M	78.61%-1.05M	-255.63%-3.66M	56.75%-1.65M	42.61%-2.49M	22.39%-14.07M	-19.11%-4.89M
Minority interest income
Net income attributable to the parent company	-0.63%-3.69M	2.18%-1.61M	-0.88%-2.52M	37.11%-8.85M	78.61%-1.05M	-255.63%-3.66M	56.75%-1.65M	42.61%-2.49M	22.39%-14.07M	-19.11%-4.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-0.63%-3.69M	2.18%-1.61M	-0.88%-2.52M	37.11%-8.85M	78.61%-1.05M	-255.63%-3.66M	56.75%-1.65M	42.61%-2.49M	22.39%-14.07M	-19.11%-4.89M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data